Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death
Open Access
- 11 March 2022
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (4) , 101821
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Impact of Exogenous Galectin-9 on Human T CellsJournal of Biological Chemistry, 2015
- Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T CellsImmunity, 2014
- Galectin-9 Activates and Expands Human T-Helper 1 CellsPLOS ONE, 2013
- Galectin-9 Functionally Impairs Natural Killer Cells in Humans and MiceJournal of Virology, 2013
- Galectin-9 promotes TGF-β1-dependent induction of regulatory T cells via the TGF-β/Smad signaling pathwayMolecular Medicine Reports, 2012
- Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunityExperimental Biology and Medicine, 2011
- Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemiaBlood, 2011
- Galectins: structure, function and therapeutic potentialExpert Reviews in Molecular Medicine, 2008
- The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunityNature Immunology, 2005
- Oligosaccharide specificity of galectins: a search by frontal affinity chromatographyBiochimica et Biophysica Acta (BBA) - General Subjects, 2002